We have collected information about Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone Caproate for you. Follow the links to find out details on Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone Caproate.
https://www.nejm.org/doi/full/10.1056/NEJMoa035140
Original Article from The New England Journal of Medicine — Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone CaproateAuthor: Paul J. Meis, Mark Klebanoff, Elizabeth Thom, Mitchell P. Dombrowski, Baha Sibai, Atef H. Moawad, Ca...
https://www.ncbi.nlm.nih.gov/pubmed/12802023
Jun 12, 2003 · The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. METHODS: We conducted a double-blind, placebo-controlled trial involving pregnant women with a documented history...Author: Paul J. Meis, Mark Klebanoff, Elizabeth Thom, Mitchell P. Dombrowski, Baha Sibai, Atef H. Moawad, Ca...
https://www.nejm.org/doi/full/10.1056/NEJM200309113491115
To the Editor: After reading the article by Meis et al. (June 12 issue),1 we strongly discourage practitioners from using 17 alpha-hydroxyprogesterone caproate in …
https://www.ncbi.nlm.nih.gov/pubmed/12968095
Sep 11, 2003 · Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. Brancazio LR, Murtha AP, Heine RP. Comment …Author: Brancazio Lr, Murtha Ap, Heine Rp
https://www.researchgate.net/publication/10712383_Prevention_of_Recurrent_Preterm_Delivery_by_17_Alpha-Hydroxyprogesterone_Caproate
Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate Article (PDF Available) in New England Journal of Medicine 348(24):2379-85 · July 2003 with 256 Reads
https://www.smfm.org/publications/280-smfm-statement-use-of-17-alpha-hydroxyprogesterone-caproate-for-prevention-of-recurrent-preterm-birth
SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth. Tags: preterm birth, prior preterm birth. Categories: SMFM Statement. back Publication Files & Links. Original Article; 409 12th Street, SW. Washington, DC 20024
https://medicalxpress.com/news/2019-10-experts-high-risk-pregnancy-published-results.html
Oct 25, 2019 · "The PROLONG trial assessed the effectiveness of weekly injections of 17-alpha-hydroxyprogesterone caproate (17-OHPC) in reducing the incidence of recurrent preterm birth and neonatal morbidity.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855838/
In one trial and one systematic review and meta-analysis , 17 alpha-hydroxyprogesterone caproate (17P) has been associated with a reduction of recurrent SPTB. It is unclear if the effects of 17P (for prior SPTB) and cerclage (for short CL) are additive in women with both risk factors.Author: Vincenzo Berghella, Dana Figueroa, Jeff M. Szychowski, John Owen, Gary D.V. Hankins, Jay D. Iams, Je...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2790283/
Treatment with 17 alpha-hydroxyprogesterone caproate (17-OHPC) reduced the risk of recurrent preterm birth in singleton gestations by one third.3 This treatment, however, proved ineffective in women with twin gestation. The current trial assesses the value of this therapy in a group of women at extremely high risk of preterm birth, those with ...Author: Steve N. Caritis, Dwight J. Rouse, Alan M. Peaceman, Anthony Sciscione, Valerija Momirova, Catherine...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449222/
17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth is recommended for use in the United States. Objective To assess the clinical effectiveness of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth ≤ 35 weeks compared to similar births in our obstetric population prior to the implementation of 17-alpha hydroxyprogesterone caproate.Author: David B. Nelson, Donald D. McIntire, Jeffrey McDonald, John Gard, Paula Turrichi, Kenneth J. Leveno
Searching for Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone Caproate?
You can just click the links above. The data is collected for you.
